chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got the shot years ago  I just got the shingles/Suspected vaccination failure; I just got the shingles about 3 months ago; Painful; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. The patient was treated with acetylsalicylic acid (Aspirin). On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and pain were recovering/resolving.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 18-MAY-2022 Reporters comment: The patient self-reported the case via interactive digital media and described the occurrence of suspected vaccination failure. The patient received Shingles vaccine, years ago from the date of reporting. After receiving Shingles vaccine, the patient got shingles about 3 months ago from the date of reporting and they were absolutely very painful. The patient was put on a prescription which helped somewhat. The patient also used roll on aspirin cream and it actually helped a lot. Additional supportive information: This case was considered as suspected vaccination failure, since the details regarding completion of the primary immunization, time to onset for event and laboratory test confirming shingles was unknown at the time of reporting. Follow up would not be possible as contact details were not available.
I've had it 3 times, I have my vaccine/Suspected vaccination failure; I've had it 3 times in the past few months; Pain is constant; Feel much older, makes working miserable, unbearable; Nerve pain; it makes working miserable, unbearable some days; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a 52-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain, feeling abnormal, post herpetic neuralgia and activities of daily living impaired. On an unknown date, the outcome of the vaccination failure, shingles, feeling abnormal and activities of daily living impaired were unknown and the outcome of the pain and post herpetic neuralgia were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, pain, feeling abnormal, post herpetic neuralgia and activities of daily living impaired to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 07-SEP-2022 Reporter's Comment: This case was received from patient via interactive digital media. The patient had the Shingles vaccine. The patient had shingles 3 times in the past few months.  The pain was constant without the blisters/rash. The patient was only 52 years old but some days the patient felt much older, shingles makes working miserable and unbearable some days. The patient keep medication on hand, but it did not help with the nerve pain, so he/she just deal mostly. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Patient had his second dose of Janssen booster dose at post vac 5mins later patient began to feel flushed and dizzy and slight fainting attemp. Patient was place in a fowler position and vital sign where obtained at 11:59 102/56 pulse 75, 12:05 117/65 pulse 91. patient is oriented X3 after 30mins. Patient drank a bottle of juice and was sent home after 30mins in post vac.
mild soreness in the arm; Fatigue after the second; Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant), PAIN IN EXTREMITY (mild soreness in the arm) and FATIGUE (Fatigue after the second) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 037A21B) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), ASCORBIC ACID (VIT C), MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and PROBIOTICS NOS for an unknown indication.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was in November 2020 and the estimated date of delivery was 10-Aug-2021. On 17-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). On an unknown date, the patient experienced PAIN IN EXTREMITY (mild soreness in the arm) and FATIGUE (Fatigue after the second). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 17-Apr-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved. At the time of the report, PAIN IN EXTREMITY (mild soreness in the arm) and FATIGUE (Fatigue after the second) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) to be possibly related. No further causality assessments were provided for PAIN IN EXTREMITY (mild soreness in the arm) and FATIGUE (Fatigue after the second).    No treatment medications were reported.  Last menstrual period was reported as beginning of November  This is a case of vaccine exposure during pregnancy with associated AEs for PT fatigue and pain in extremity for this female.   This case was linked to MOD-2021-278047 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Sep-2021: Follow up received and updated contact information. Changes from the initial document included addition of event and change in PT term for another event; Sender's Comments: This is a case of vaccine exposure during pregnancy with associated AEs for PT fatigue and pain in extremity for this female.
Had warm to touch, painful, raised, area on Right Upper Inner Calf in right leg. Dx-DVT- Blood Clot in right mid leg. Dx via sonogram on 05/11/2021.
Increasing pain, numbness, loss of range of motion, nerve impingement and frozen shoulder starting day of 2nd dose. Sought medical care 4 months ago, no definitive diagnosis or successful treatment
Has a fever like 99.4; Sore throat; Stuffy nose; This is a spontaneous report from a contactable consumer. This contactable consumer (mother) reported for a male patient (son). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 31Jul2021 (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration (Batch/Lot was not reported) as dose 1, single for covid-19 immunisation. On an unspecified date in 2021, the patient had a fever like 99.4 and he had a sore throat and he had like a stuffy nose and she just wanted to know that like how long the side effects was supposed to be or he was experiencing something else. The patient underwent lab tests and procedures which included body temperature: 99.4 on an unspecified date in 2021. The clinical outcome of the events were unknown.  Follow-up activities closed. Batch/lot number is not available.
pt recvd DTP/OPV on 9MAR92 & on 10MAR approx 30 hrs following vax, pt had a febrile convuls @ home; taken to ER; fever 104; given APAP & sent home; nofurther convuls;
Information has been received from a registered nurse concerning a 38 year old female with no allergies or medical history who on 5/19/2006 was vaccinated SC with a dose of varicella virus vaccine live. There was no concomitant medication. Six to seven days after vaccination, on approximately 5/25/2006, the patient broke out in a rash at the sit of injection under the right arm. This one rash was the size of a fifty cent piece with five raised areas. The rash got bigger to the size of a silver dollar with a tail. The rash was more of an oblong shape that looked lumpy. It was noted to be more of a vesicular rash and there were approximately seven raised areas that were itchy and looked like hives. The patient was treated wit diphenhydramine hydrochloride Benadryl. The rash was reported to be better and about the size of a quarter with a bruised color and purple color and the lesion amounts were less. At the time of the report, the patient was recovering. no diagnostic laboratory tests were performed. A product quality complaint was not involved. The patients experience was considered to be an other important medical event by the reporter (OMIC). Additional information has been requested.
low grade temp on 16OCT93, APAP given; began jerking movements of all extremities; eyes rolled back; lethargy, shallow breathing; fever;
Redness, puffiness and swelling the size of a quarter. Grandfather is a physician and treated her with Cephalexin
Reddiness around shot area. Itching  times 4 days. No treatment was necessary.
About 2 1/2 hours after the shot, I began having discomfort in my chest. I first thought it was heartburn (which I don't typically experience, in fact, haven't outside of pregnancy.) However, the feeling did not ease up. I went down to ask the school nurse if it could be a side effect of the shot, but as I walked, I began to get lightheaded. She checked my blood pressure and found it to be unusually high (180/90), but it lowered on a subsequent check to about 150/90 (still atypically high for me.) She suggested I get checked out. I went to the emergency room where they ran a series of tests that all came back negative (see below). All told, my symptoms included: -Tightness/discomfort in my chest - lasted about 8 hours -Difficulty swallowing (like a lump in my throat) - lasted about 8 hours -Shortness of breath - lasted about 8 hours -Redness in the eyes - lasted about 8 hours -My right eye was crusted shut two mornings later. Just that one morning. Two days after the shot, all symptoms had cleared up without treatment.
This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (extremely sick), CHILLS (chills), PAIN (body aches), HEADACHE (Headache) and MYALGIA (muscle aches) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Psoriasis.    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced ILLNESS (extremely sick), CHILLS (chills), PAIN (body aches), HEADACHE (Headache) and MYALGIA (muscle aches). On 13-Feb-2021, the patient experienced ARTHRALGIA (joint aches). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) for Adverse event, at an unspecified dose and frequency. On 14-Feb-2021, ILLNESS (extremely sick) and CHILLS (chills) had resolved. At the time of the report, PAIN (body aches), HEADACHE (Headache), MYALGIA (muscle aches) and ARTHRALGIA (joint aches) outcome was unknown.
Vaccinations were received on 04/06/09 (received DTaP, MMR, VZV). On 04/08/09 developed swelling, itching, redness in left arm at site just below the shoulder. Warm to touch. Redness lessened later in same day.
09/06/2006 at 10 AM:  Administered DTaP IM to left leg; IPV, MMR SQ to left leg. ER phoned health department at 4pm on 09/06/2006 to state that child had swollen lips.  Given epi and benadryl with good response.  No respiratory problems.  No other symptoms other than swollen lips. Follow-up Information 20-OCT-2006: Observed 30min post vaccination.
67 y/o M with a hx of NHL (stable) received varicella zoster vaccine 0.65 ml on 3/10/08.  2 days after having received the vaccine, pt started developing a rash along with redness and itching on feet.  This later progressed to his legs, abdomen and his arms.  3/24-pt had swelling in R armpit, achiness in joints, SOB but no cough/congestion.  3/26-pt admitted with cough.  All cultures came back (-).  Pt had prolonged hosp. for resp. failure secondary hypersensitivity pneumonitis reaction.  09/19/2008 MR received for DOS 3/26-4/17/2008 with D/C DX:  Hypersensitivity rash-resolving.  Diffuse pulmonary opacities, pneumonia vs hypersensitivity pneumonitis.  Hx of low grade lymphoproliferative d/o, hx of non-hodgkins lymphoma, benign prostatic hypertrophy, hyperlipidemia.  Pt presented with worsening ascending rash beginning on March 12, 08, 2 days s/p Zostavax . Rash was pruritic and started on the dorsum of the feet and progressed upwards to the torso and upper extremities. Vesicular appearance on violaceous papules and plaques. Pt also developed joint pain in the hands, knees and elbows, which were sensitive to touch. Pt further progressed to develop a dry, non-productive cough and SOB at which point he was admitted. Etiology of sx unknown. Rheum consult for transient arthralgias ? vasculitis. Derm consult with assessment: likely vaccine induced EM.  Respiratory status declined, and pt placed on NC O2, then BiPAP. Transfered to ICU in unstable and guarded condition for possible intubation.  Developed a LLL infiltrate and dx with pneumonia.  TX with abx, antivirals and ultimately steroids. Extubated 4/14/08. Tranfered to SNF on 4/17/08 for further rehab.
Patient son informed pharmacist that patient was hospitalized on 7-19-16 due to receiving PREVNAR on 6-21-16.
shingles; Itching arm; Bumps under right arm; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included chickenpox and shingles.   On 17th October 2019, the patient received the 1st dose of Shingrix. On 20th October 2019, 3 days after receiving Shingrix, the patient experienced shingles, itchy upper limbs and papular rash. On an unknown date, the outcome of the shingles, itchy upper limbs and papular rash were unknown.   It was unknown if the reporter considered the shingles, itchy upper limbs and papular rash to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in right deltoid region. The patient stated that after vaccination experienced itching and bumps under her right arm and then developed shingles on the right side of the chest regions and then right side of her back. The patient consented to follow up.
No adverse event/ no known pt adverse events; Indavertently administered improperly stored GARDASIL 9/ Temps went out of range. Vaccines given despite excursion.; This spontaneous report was received from a licensed practical nurse (LPN) regarding to a 15-year-old male patient. The patient's concurrent conditions, pertinent medical history, concomitant therapies, drug reactions, and allergies were not provided.  On 03-NOV-2021, the patient was vaccinated, for prophylaxis, intramuscularly with an improperly stored (product storage error) dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) lot number T028929, with an expiration date of 08-MAR-2023 (dose, strength and formulation were not reported), subcutaneously with the dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) lot number U010396), with an expiration date of 01-APR-2023 (also reported as 28-SEP-2022, upon internal validation, this is an incorrect expiry date) (dose, strength and formulation were not reported), subcutaneously with the dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin) (M-M-R II) lot number T020655, with an expiration date of 16-JUN-2022 (also reported as 26-MAR-2022, upon internal validation, this is an incorrect expiry date) (dose, strength and formulation were not reported), intramuscularly with the dose of hepatitis a vaccine inact (HAVRIX), lot number 2JD3Y, with expiration date of 04-DEC-2022 (dose, strength and formulation were not reported), intramuscularly with the dose of diphteria vaccine toxoid, hepatitis b vaccine rhbsag (yeast), pertussis vaccine acellular 3-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (PEDIARIX), lot number J7H4D , with expiration date of 23-MAR-2022 (dose, strength and formulation were not reported), intramuscularly with the first dose of meningococcal vaccine a/c/y/w conj (diptox)(MENACTRA), lot number U7190AA, with expiration date of 16-JAN-2023 (dose, strength and formulation were not reported), intramuscularly with the dose of diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, tetanus vaccine toxoid (BOOSTRIX), lot number C5863AA, with expiration date of 13-APR-2023 (dose, strength and formulation were not reported).  There were no additional adverse event details. Administered dose of vaccine experienced the temperature excursion of 27.2 degrees Fahrenheit and 49.8 degrees Fahrenheit for 8 hours 30 minutes and 21 hours and 15 minutes respectively. There were no previous excursions reported.  The outcomes of all the events for all the vaccines administered was not reported. Action taken for all the vaccines was not applicable. The causality assessment between all the adverse events and all of the vaccines administered was not applicable.  This is one of nine reports received from the same reporter. ; Sender's Comments:  US-009507513-2202USA007811: US-009507513-2202USA007814: US-009507513-2202USA007815: US-009507513-2202USA007817: US-009507513-2202USA007818: US-009507513-2202USA007812: US-009507513-2202USA002574: US-009507513-2202USA007813:
Lost sense of taste approximately 1 week after receiving vaccine.  Have had no treatment because I don't know what to do.
Presented with fever @ 7:30 AM on 6/19/2019. Later had large area at injection site, red and warm to touch. Was seen in ED and it was decided the cause was an immunization site reaction and not cellulitis.
her body ached; shivers; cough; runny nose; feels sad; not feeling well; This spontaneous case was reported by a patient and describes the occurrence of COUGH (cough), RHINORRHOEA (runny nose), DEPRESSED MOOD (feels sad), FEELING ABNORMAL (not feeling well) and MYALGIA (her body ached) in a 69-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Aug-2023, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 21-Aug-2023, the patient experienced COUGH (cough), RHINORRHOEA (runny nose), DEPRESSED MOOD (feels sad), FEELING ABNORMAL (not feeling well) and CHILLS (shivers). On an unknown date, the patient experienced MYALGIA (her body ached). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, COUGH (cough) had not resolved, RHINORRHOEA (runny nose), DEPRESSED MOOD (feels sad), FEELING ABNORMAL (not feeling well) and CHILLS (shivers) had resolved and MYALGIA (her body ached) outcome was unknown.            Concomitant medication details not reported by the reporter.
Information has been received from a physician concerning a female consumer who on approximately 15-SEP-2007 was vaccinated with Gardasil vaccine. On approximately 15-SEP-2007,  the patient developed a 1.5 cm nodule on her deltoid which was at the injection site. The dates the patient received the first and second doses were unspecified. The patient's nodule on her deltoid persisted. No further information was provided. Additional information has been requested.
Throwing up, diarrhea, dehydrated, no food or liquid intake. Lethargic, would not wake up. Taken to urgent care, was given 400cc IV Fluid. Released to recover at home. Is starting to move about, but still not taking in much food or water.
This spontaneous report was received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On an unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 (dose, route of administration, lot # and expiration date were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 34 degrees Fahrenheit ; 32 to 35 degrees Fahrenheit for 64 hours. Data logger was not involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1703USA012527: US-009507513-1703USA012528: US-009507513-1703USA012526:
Allergic reaction, skin rash, itching and hives. A cause has been identified. This started 1 1/2 hours ago; Patient was at pediatrician's office yesterday, received some vaccinations, started with hives about 1.5 hours ago, only new vaccine that he hasn't had was HPV. Now hives with itching and burning covering full abdomen and back, bilateral arms, neck, and face. Denies any difficulty breathing or swallowing. Took BENADRYL 25mg at home about 20 minutes ago and feeling slightly better. No previous Hx of allergic reactions in past, and is still present. The patient has had a skin rash and itching but not had swelling or trouble swallowing. No difficulty breathing, dizziness or fainting episodes. Instructions (Continue taking the BENADRYL as needed for rash and itching).  Warnings: General Warnings: Return or contact your physician immediately if your condition worsens or changes unexpectedly, if not improving as expected, or if other problems arise. Prescription Medications: Prednisone 20 mg: take 2 orally every day for 4 days. Dispense sufficient quantity. No refills. (Start Prednisone tomorrow morning). Ranitidine 150 mg: take 1 orally every 12 hours. Dispense thirty (30). No refills. (PRN rash).